Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Boden

Showing results (21-30 of 190) with videos related to

Pageof 19
Sort By:
Annals of Internal Medicine|August 1, 1983
Making intensified insulin treatment saferG Boden, R D Hoeldtke
Endocrinology|June 1, 1973
Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA)G Boden, W Y Chey
The New England Journal of Medicine|March 10, 1977
Familial hyperglucagonemia--an autosomal dominant disorderG Boden, O E Owen
Gastroenterology|September 1, 1975
Reversibility of pyloric sphincter dysfunction in gastric ulcerR S Fisher, G Boden
The American Journal of Digestive Diseases|June 1, 1976
Gastrin inhibition of the pyloric sphincterR S Fisher, G Boden
Endocrinology|December 1, 1993
Effects of oleate and fatty acids from omental adipocytes on insulin uptake in rat liver cellsJ W Kolaczynski, G Boden
European Journal of Clinical Investigation|May 25, 2002
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunctionG Boden, G I Shulman
Diabetes|October 27, 1999
Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetesG Boden, X Chen, M Polansky
Diabetes Care|August 11, 2000
Thalidomide impairs insulin action on glucose uptake and glycogen synthesis in patients with type 2 diabetesN Iqbal, M Zayed, G Boden
Annals of Internal Medicine|July 15, 1994
Glucose transporter proteins in human insulinomaG Boden, E Murer, M Mozzoli
Pageof 19

Showing results (21-30 of 190) with videos related to

Sort By:
Pageof 19
Annals of Internal Medicine|August 1, 1983
Making intensified insulin treatment saferG Boden, R D Hoeldtke
Endocrinology|June 1, 1973
Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA)G Boden, W Y Chey
The New England Journal of Medicine|March 10, 1977
Familial hyperglucagonemia--an autosomal dominant disorderG Boden, O E Owen
Gastroenterology|September 1, 1975
Reversibility of pyloric sphincter dysfunction in gastric ulcerR S Fisher, G Boden
The American Journal of Digestive Diseases|June 1, 1976
Gastrin inhibition of the pyloric sphincterR S Fisher, G Boden
Endocrinology|December 1, 1993
Effects of oleate and fatty acids from omental adipocytes on insulin uptake in rat liver cellsJ W Kolaczynski, G Boden
European Journal of Clinical Investigation|May 25, 2002
Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunctionG Boden, G I Shulman
Diabetes|October 27, 1999
Disruption of circadian insulin secretion is associated with reduced glucose uptake in first-degree relatives of patients with type 2 diabetesG Boden, X Chen, M Polansky
Diabetes Care|August 11, 2000
Thalidomide impairs insulin action on glucose uptake and glycogen synthesis in patients with type 2 diabetesN Iqbal, M Zayed, G Boden
Annals of Internal Medicine|July 15, 1994
Glucose transporter proteins in human insulinomaG Boden, E Murer, M Mozzoli
Pageof 19